Funded Tech Companies

Priothera

Headquartered in Saint-Louis, Priothera has funding from Bpifrance.

Company Overview

Company Name
Priothera
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
57 Avenue Général de Gaulle
Saint-Louis, 68300
France
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
Priothera is a late-stage biopharma company pioneering the development of mocravimod, a potential new standard of care in hematologic cancers, in addition to cellular therapies such as hematopoietic cell transplantation and CAR-T cell therapies. Mocravimod is being developed as an adjunctive and maintenance therapy for hematological malignancies requiring allogeneic hematopoietic cell transplant (allo-HCT), focusing initially on acute myeloid leukemia (AML).
Profile
Priothera LinkedIn Company Profile
Social Media
Priothera Company Twitter Account
Company News
Priothera News
Facebook
Priothera on Facebook
YouTube
Priothera on YouTube
Last Transaction
6/24/2025

Financing History

Date
Type
Amount
Venture Equity
$2,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Florent Gros
  Florent Gros LinkedIn Profile  Florent Gros Twitter Account  Florent Gros News  Florent Gros on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Prioria Robotics | Prisidio

 

Share this article

 


About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary